In essence, “monomer” and “molecular building block” are two ways of describing the same class of substances in oligonucleotide chemistry. Both refer to the preassembled units used for chemical synthesis of oligonucleotide […]
Why Impurity Analysis Matters in Oligonucleotide Quality Control In the quality control of chemically synthesized oligonucleotides, impurity analysis is a critical component for ensuring drug safety, efficacy, and consistent product […]
Delivering therapeutic agents to the heart has long been a formidable challenge. While cardiovascular diseases remain the world’s leading cause of mortality, modern therapeutic strategies—including RNA medicines, protein drugs, and […]
Engineering the Future of Sustainable Bioproduction with BOC Sciences The growing need for sustainable and efficient production systems has positioned microbial engineering and synthetic biology at the forefront of the […]
Introduction: The Next Frontier of Lipid Nanoparticles (LNPs) in Cancer Nanomedicine For decades, cancer nanomedicine has pursued a central goal — to deliver potent therapies directly to tumors while sparing healthy […]
The Rising Global Demand for GLP-1 Therapies As global rates of diabetes and obesity continue to climb, GLP-1 receptor agonists (GLP-1 RAs) have attracted tremendous attention for their remarkable glucose-lowering and […]
Hyperlipidemia is one of the most significant controllable risk factors for cardiovascular and cerebrovascular diseases such as myocardial infarction and stroke. These conditions have long ranked among the leading causes […]
A very high proportion of approved drugs contain nitrogen-containing heterocyclic structures. Taking the period from 2013 to 2023 (11 years) as an example, 82% of all approved drugs featured at […]
Transfer RNA-derived small RNAs (tsRNAs) are a class of small non-coding RNAs (sncRNAs) generated from precursor or mature tRNAs through specific cleavage by ribonucleases such as Angiogenin (ANG), Dicer, and […]
Technology Overview Aptamer-ASO chimeras are innovative bifunctional oligonucleotide therapeutics that combine the high-affinity targeting of aptamers with the gene-silencing capabilities of antisense oligonucleotides (ASOs) [1]. This hybrid design enables precise delivery […]